About Us
Corporate Identity
A world-class biopharmaceutical company specializing in recombinant protein therapeutics
Built on outstanding R&D talent and robust research capabilities
An anticancer platform and pipeline targeting common mechanistic hubs associated with metastasis, recurrence, and treatment resistance in solid tumors
A recombinant protein platform targeting upstream core signaling axes in shared pathways of chronic inflammatory diseases
Developing new business models through open innovation
Committed to developing novel therapies for healthier lives
